Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe Dal-Pizzol

Showing results (1-10 of 444) with videos related to

Pageof 45
Sort By:
Critical Care Medicine|September 3, 2004
Alternative activated macrophage: a new key for systemic inflammatory response syndrome and sepsis treatment?Felipe Dal-Pizzol
Lancet (London, England)|April 30, 2002
Drug advertisements in less-developed countriesFelipe Dal-Pizzol
Chest|November 9, 2024
ResponseFelipe Dal-Pizzol, Cristiane Ritter
The New England Journal of Medicine|July 22, 2011
Functional disability 5 years after ARDSFelipe Dal-Pizzol, Cristiane Ritter
Neural Regeneration Research|July 10, 2025
NLRP3 inflammasome: A link between systemic infection and Alzheimer's diseaseTatiana Barichello, Felipe Dal-Pizzol
Revista Brasileira De Terapia Intensiva|August 7, 2013
Searching for the Holy Grail: where do we go with the current biomarkers for sepsis?Felipe Dal-Pizzol, Cristiane Ritter
Revista Brasileira De Terapia Intensiva|August 7, 2013
How do you prefer your resuscitation solution?: Do you want a little bit more salt?Felipe Dal-Pizzol, Mervyn Singer
Chest|October 10, 2024
ResponseFelipe Dal-Pizzol, Cristiane Ritter
Critical Care Medicine|April 29, 2022
The authors replyTatiana Barichello, Tarek Sharshar, Felipe Dal-Pizzol
Journal of Neuroimmunology|January 15, 2017
Polarization of microglia and its role in bacterial sepsisMonique Michels, Beatriz Sonai, Felipe Dal-Pizzol
Pageof 45

Showing results (1-10 of 444) with videos related to

Sort By:
Pageof 45
Critical Care Medicine|September 3, 2004
Alternative activated macrophage: a new key for systemic inflammatory response syndrome and sepsis treatment?Felipe Dal-Pizzol
Lancet (London, England)|April 30, 2002
Drug advertisements in less-developed countriesFelipe Dal-Pizzol
Chest|November 9, 2024
ResponseFelipe Dal-Pizzol, Cristiane Ritter
The New England Journal of Medicine|July 22, 2011
Functional disability 5 years after ARDSFelipe Dal-Pizzol, Cristiane Ritter
Neural Regeneration Research|July 10, 2025
NLRP3 inflammasome: A link between systemic infection and Alzheimer's diseaseTatiana Barichello, Felipe Dal-Pizzol
Revista Brasileira De Terapia Intensiva|August 7, 2013
Searching for the Holy Grail: where do we go with the current biomarkers for sepsis?Felipe Dal-Pizzol, Cristiane Ritter
Revista Brasileira De Terapia Intensiva|August 7, 2013
How do you prefer your resuscitation solution?: Do you want a little bit more salt?Felipe Dal-Pizzol, Mervyn Singer
Chest|October 10, 2024
ResponseFelipe Dal-Pizzol, Cristiane Ritter
Critical Care Medicine|April 29, 2022
The authors replyTatiana Barichello, Tarek Sharshar, Felipe Dal-Pizzol
Journal of Neuroimmunology|January 15, 2017
Polarization of microglia and its role in bacterial sepsisMonique Michels, Beatriz Sonai, Felipe Dal-Pizzol
Pageof 45